MEDTRONIC HEART VALVES DIVISION EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
|
Back to Search Results |
|
Model Number D-EVOLUTFX-2329 |
Device Problems
Difficult or Delayed Activation (2577); Malposition of Device (2616); Device Dislodged or Dislocated (2923)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 03/12/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
Continuation of d10: section d information references the main component of the system.Other relevant device(s) are: product id: evolutfx-26, serial/lot #: (b)(6), ubd: 30-nov-2025, udi#: (b)(4).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Medtronic received information that during the implant of this transcatheter bioprosthetic valve in a patient with minimal calcification, the valve was deployed to a depth of 3 mm on the non-coronary cusp (ncc) and the left coronary cusp (lcc).As the cine timed off during the deployment, fluoroscopy showed that the valve paddles were still attached to the delivery catheter system (dcs) tabs; however, the implanting physician pulled back the dcs, causing the valve to dislodge to a depth of -2 mm and 0 mm on the ncc and lcc.No regurgitation was noted.Subsequently, a second non-medtronic valve was successfully implanted.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Additional information was received indicating that pre-implant balloon aortic valvuloplasty (bav) was not performed.The right femoral artery was used as the access site for the delivery catheter system (dcs).An extra small curved non-medtronic (safari) guidewire was used during the procedure.It was reported that the cause of the dislodgement was unknown, however, it was thought that the nosecone caused the dislodgement because fluoroscopy went off as the delivery catheter system (dcs) was withdrawn.Per the physician, minimal leaflet calcification and a low gradient contributed to the dislodgement.
|
|
Manufacturer Narrative
|
Corrected data: h6 additional codes medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|